Dr. Strauss on Mitigating Oral Mucositis Symptoms
William Strauss, MD, Executive Director, Medical Affairs, AMAG Pharmaceuticals, Inc., discusses a study that analyzed mitigating oral mucositis symptoms in patients with head and neck cancers being treated with chemoradiation therapy.
William Strauss, MD, Executive Director, Medical Affairs, AMAG Pharmaceuticals, Inc., discusses a study that analyzed mitigating oral mucositis symptoms in patients with head and neck cancers being treated with chemoradiation therapy.
The study enrolled 120 patients with head and neck cancers who were scheduled to receive a combination of chemotherapy and radiation therapy. Patients were randomized to receive MuGard, an oral mucoadhesive hydrogel considered a device by the FDA, or a saline-bicarbonate rinse.
The patients received 5-10cc of MuGard 6 times daily or the control rinse of saline-bicarbonate​. Saline-bicarbonate rinse was labeled as a sham because it is currently recommended by the NCI, though there is debate over its efficacy.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
